A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.

MLA

Balasenthil, Seetharaman, et al. “A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.” JNCI: Journal of the National Cancer Institute, vol. 109, no. 8, Aug. 2017, pp. 1–10. EBSCOhost, https://doi.org/10.1093/jnci/djw341.

APA

Balasenthil, S., Ying Huang, Suyu Liu, Marsh, T., Jinyun Chen, Stass, S. A., KuKuruga, D., Brand, R., Nanyue Chen, Frazier, M. L., Lee, J. J., Srivastava, S., Sen, S., Killary, A. M., Huang, Y., Liu, S., Chen, J., Chen, N., Jack Lee, J., & McNeill Killary, A. (2017). A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. JNCI: Journal of the National Cancer Institute, 109(8), 1–10. https://doi.org/10.1093/jnci/djw341

Chicago

Balasenthil, Seetharaman, Ying Huang, Suyu Liu, Tracey Marsh, Jinyun Chen, Sanford A. Stass, Debra KuKuruga, et al. 2017. “A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.” JNCI: Journal of the National Cancer Institute 109 (8): 1–10. doi:10.1093/jnci/djw341.